uniQure N.V. announced the appointment of Alexander Kuta, Ph.D., as Senior Vice President of Regulatory Affairs. Dr. Kuta has more than 25 years of regulatory experience within the industry, having previously held leadership positions at Genzyme Corporation, EMD Serono, AMAG Pharmaceuticals and Lantheus Medical Imaging. Dr. Kuta will be responsible for leading all global regulatory affairs for uniQure’s gene therapies. He will report to Matt Kapusta, Chief Executive Officer of the company, and will be based in the company’s Lexington, Massachusetts facility. Dr. Kuta was most recently with EMD Serono as Vice President of Research & Development Global Regulatory Affairs and a member of the U.S. Leadership Team.